Interim CEO Brent Shafer said the medical products maker is ready to begin a new era after several years of “heavy lifting” ...

Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an ...

Processa Pharmaceuticals, Inc. announced its participation in the 2025 BIO CEO & Investor Conference taking place on February 10-11, 2025, in New York City. The company's management will present a ...

Feb. 07, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals ... today announced its participation in the 2025 BIO CEO & Investor Conference being held February 10-11, 2025, at the New York Marriott ...

Using the 2 Stage Free Cash Flow to Equity, Sonoma Pharmaceuticals fair value estimate is US$1.97 Sonoma Pharmaceuticals is estimated to be 34% overvalued based on current share price of US$2.65 ...

Rodriguez, the CEO and President of Rigel Pharmaceuticals Inc. (NASDAQ:RIGL), recently sold shares worth $200,075, according to a recent ... Finally, in the third quarter of 2024, Rigel achieved a net ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that Seth ...

Investors interested in arranging a meeting with the Company’s management during the conference can register on the BIO CEO & Investor Conference website here. Tonix Pharmaceuticals Holding Corp ...

Investors interested in arranging a meeting with the Company's management during the conference can register on the BIO CEO & Investor Conference website here. Tonix Pharmaceuticals Holding Corp. * ...